Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Friday, April 21, 2023
3:45 PM – 4:30 PM .
Learning Objectives:
Describe the utility of biosimilars for IBD and their potential impact on reducing costs and improving access to treatment
Assess common misconceptions regarding biosimilar testing and discuss the approval process for determining the safety and efficacy of biosimilars in clinical practice
Evaluate the most recent data regarding the safety and efficacy of current and emerging biosimilars for the treatment of IBD
Outline strategies to incorporate the use of biosimilars in clinical practice, including clinician and patient education on their safety and efficacy as well as appropriate reasons for switching medications